参考文献/References:
[1] 钟勇,江时森.调脂药物对糖尿病状态下糖代谢的影响及其机制的研究进展[J]. 中华老年心脑血管病杂志,2013,15(9):990-992,DOI:10.3969/j.issn.1009-0126.2013.09.030.
[2] Zhang A, Sun H, Yang B,et al. Predicting new molecular targets for rhein using network pharmacology[J].BMC Syst Biol,2012,6:20.DOI:10.1186/1752-0509-6-20.
[3] Han MS, Jung DY, Morel C,et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation[J].Science,2013,339(6116):218-222.DOI:10.1126/science.1227568.
[4] Meng Z, Yan Y, Tang Z,et al. Anti-hyperuricemic and nephroprotective effects of rhein in hyperuricemic mice[J].Planta Med,2015,81(4):279-285.DOI:10.1055/s-0034-1396241.
[5] Yu C, Qi D, Sun JF,et al. Rhein prevents endotoxin-induced acute kidney injury by inhibiting NF-κB activities[J].Sci Rep,2015,5:11822.DOI:10.1038/srep11822.
[6] 段淑芳,胡江.大黄酸对2型糖尿病大鼠胰腺的保护作用[J].浙江实用医学,2016,21(3):157-159,DOI:10.16794/j.cnki.cn33-1207/r.2016.03.001.
[7] Kim KE,Heo JS, Han S,et al.Blood concentrations of lipopolysaccharide-binding protein, high-sensitivity C-reactive protein, tumor necrosis factor-α, and interleukin-6 in relation to insulin resistance in young adolescents[J].Clin Chim Acta,2018,486:115-121.DOI:10.1016/j.cca.2018.07.042.
[8] Heo SK,Yun HJ,Noh EK,et al.Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production[J].Vascul Pharmacol,2010,53(1-2):28-37.DOI:10.1016/j.vph.2010.03.002.
[9] Olsnes C,Olofsson J,Aarstad HJ.MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-α secretion following OK-432 in vitro stimulation of purified human monocytes[J].Scand J Immunol,2011,74(2):114-125.DOI:10.1111/j.1365-3083.2011.02555.x.
[10] Lin YJ,Hu G,Li KJ,et al.The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin.Arch Pharm Res,2015,38(5):885-892.DOI:10.1007/s12272-014-0423-4.
[11] Seifert EL,Estey C,Xuan JY,et al.Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2emission during long-chain fatty acid oxidation[J].J Biol Chem,2010,285(8):5748-5758.DOI: 10.1074/jbc.M109.026203.
[12] 李彩,魏洁,甄永占,等.赖氨大黄酸对KK/HJJ糖尿病小鼠胰岛素抵抗的改善作用及其机制[J]. 吉林大学学报:医学版,2017,(6):1074-1079.DOI:10.13481/j.1671-587x.20170602.
[13] 迟铖,金苗苗,母义明,等.大黄酸上调糖尿病大鼠脂肪组织PPAR-γ及GluT-4表达并改善胰岛素敏感性[J].中国糖尿病杂志,2008,16(12):746-748.DOI:10.3321/j.issn:1006-6187.2008.12.015.
[14] 李柯,卢斌,王魏,等.大黄酸对胰岛素信号通路及其负性调控蛋白蛋白酪氨酸磷酸酶1B的影响[J]. 医学研究生学报,2018,31(7):709-713.DOI:10.16571/j.cnki.1008-8199.2018.07.008.
[15] Tsuchiya K,Tanaka J,Shuiqing Y,et al.FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis[J].Cell Metab,2012,15(3):372-381. DOI: 10.1016/j.cmet.2012.01.018.
[16] Hughes KJ,Meares GP,Hansen PA,et al.FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide[J].J Biol Chem,2011,286(10):8338-8348. DOI:10.1074/jbc.M110.204768.
[17] Sedger LM,McDermott MF. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future[J].Cytokine Growth Factor Rev,2014,25(4):453-472. DOI:10.1016/j.cytogfr.2014.07.016.
[18] Nandipati KC,Subramanian S,Agrawal DK. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance[J].Mol Cell Biochem,2017,426(1-2):27-45.DOI:10.1007/s11010-016-2878-8.
[19] 黄淼,马健,杨翠华,等.大黄酸对db/db小鼠胰岛功能及炎症氧化损伤标志物表达的影响[J].中国药物与临床,2013,13(8):976-979.DOI:10.11655/zgywylc2013.08.002.
[20] Wei J,Zhen YZ,Cui J,et al. Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver disease[J].Arch Pharm Res,2016,39(7):960-969. DOI:10.1007/s12272-016-0770-4.
[21] Ruderman NB,Carling D,Prentki M,et al.AMPK,insulin resistance,and the metabolic syndrome[J].J Clin Invest,2013,123(7):2764-2772.DOI:10.1172/JCI67227.
[22] Lv Q,Zhen Q,Liu L,et al.AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells[J].Life Sci,2015,131:23-29.DOI:10.1016/j.lfs.2015.03.003.
[23] Sheng X,Wang M,Lu M,et al.Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice[J].Am J Physiol Endocrinol Metab,2011,300(5):E886-E893.DOI:10.1152/ajpendo.00332.2010.
[24] Sheng X,Zhu X,Zhang Y,et al.Rhein protects against obesity and related metabolic disorders through liver X receptor-mediateduncoupling protein 1 upregulation in brown adipose tissue[J].Int J Biol Sci,2012,8(10):1375-1384.DOI:10.7150/ijbs.4575.
[25] 金苗苗,迟铖,母义明,等.大黄酸改善糖尿病大鼠空腹血糖、胰岛素敏感性并增强肝脏PPARγ和GLUT-2的表达[J].中华内分泌代谢杂志,2008,24(5):537-541.DOI: 10.3321/j.issn:1000-6699.2008.05.021.
[26] Zhang Y,Fan S,Hu N,et al.Rhein reduces fat weight in db/db mouse and prevents diet-induced obesity in C57Bl/6 mousethrough the inhibition of PPARγ signaling[J].PPAR Res,2012,2012:374936. DOI:10.1155/2012/374936.
[27] 李佳佳,梁耀月,董世芬,等.大黄酸对3T3-L1前脂肪细胞增殖分化及相关基因表达的影响[J].中医药信息,2017,34(1):1-5.DOI:1002-2406( 2017)01-0001-05.
相似文献/References:
[1]罗俊婷 胡欣 陈国芳 刘超.骨膜蛋白与代谢性疾病[J].国际内分泌代谢杂志,2018,38(01):26.[doi:10.3760/cma.j.issn.1673-4157.2018.01.007]
Luo Junting,Hu Xin,Chen Guofang,et al.Periostin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(03):26.[doi:10.3760/cma.j.issn.1673-4157.2018.01.007]
[2]夏心怡 张洪梅.肠道菌群及其代谢产物调节糖脂代谢的机制[J].国际内分泌代谢杂志,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
Xia Xinyi,Zhang Hongmei.Regulating mechanism of glycolipid metabolism by intestinal microbiota and its metabolites[J].International Journal of Endocrinology and Metabolism,2018,38(03):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
[3]沈祯敏 邵莉.整合素相关蛋白及其配体在糖脂代谢中的作用[J].国际内分泌代谢杂志,2018,38(05):336.[doi:10.3760/cma.j.issn.1673-4157.2018.05.013]
Shen Zhenmin,Shao Li.Roles of integrin associated protein and its ligands in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2018,38(03):336.[doi:10.3760/cma.j.issn.1673-4157.2018.05.013]
[4]严克敏 朱惠娟 龚凤英.红花黄色素改善肝功能和糖脂代谢作用的研究进展[J].国际内分泌代谢杂志,2019,39(02):97.[doi:10.3760/cma.j.issn.1673-4157.2019.02.006]
Yan Kemin,Zhu Huijuan,Gong Fengying.Advances in the roles of safflower yellow in improving liver function and glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(03):97.[doi:10.3760/cma.j.issn.1673-4157.2019.02.006]
[5]杜苏苏,李晓南.姜黄素对非酒精性脂肪性肝病的调控作用[J].国际内分泌代谢杂志,2020,40(06):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
Du Susu,Li Xiaonan.Regulatory effects of curcumin on nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2020,40(03):399.[doi:10.3760/cma.j.cn121383-20200117-01026]
[6]梁源,孙立君,尹悦,等.消化内分泌与糖脂代谢[J].国际内分泌代谢杂志,2021,41(04):290.[doi:10.3760/cma.j.cn121383-20210415-05028]
Liang Yuan,Sun Lijun,Yin Yue,et al.Gut endocrine in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2021,41(03):290.[doi:10.3760/cma.j.cn121383-20210415-05028]
[7]李小红,陈频.新型脂肪细胞因子Metrnl在糖脂代谢中作用的研究进展[J].国际内分泌代谢杂志,2022,42(02):138.[doi:10.3760/cma.j.cn121383-20201027-10034]
Li Xiaohong,Chen Pin..Research progress on the role of novel secretory adipokine-Metrnl in glucose and lipid metabolism[J].International Journal of Endocrinology and Metabolism,2022,42(03):138.[doi:10.3760/cma.j.cn121383-20201027-10034]
[8]杨亚梅,朱惠娟.催产素对摄食及糖脂代谢调节作用的研究进展[J].国际内分泌代谢杂志,2023,43(01):54.[doi:10.3760/cma.j.cn121383-20210426-04069]
Yang Yamei,Zhu Huijuan..Research progress of oxytocin on eating behavior and glycolipid metabolism regulation[J].International Journal of Endocrinology and Metabolism,2023,43(03):54.[doi:10.3760/cma.j.cn121383-20210426-04069]
[9]胡雯婧,朱惠娟,龚凤英.成纤维细胞生长因子21治疗肥胖症及其相关代谢性疾病的研究进展[J].国际内分泌代谢杂志,2023,43(02):117.[doi:10.3760/cma.j.cn121383-20220125-01048]
Hu Wenjing,Zhu Huijuan,Gong Fengying..Research progress of fibroblast growth factor 21 in the treatment of obesity and its associated metabolic diseases[J].International Journal of Endocrinology and Metabolism,2023,43(03):117.[doi:10.3760/cma.j.cn121383-20220125-01048]